Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1125 participants.

Also called NCT06587737

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,125 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06587737
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06587737. Randomized; quadruple masking; primary purpose prevention. Start 2026-09-30 (anticipated); primary completion 2028-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage
Acronym
CoVasc-ICH2
Condition
Colchicine
Condition
ICH - Intracerebral Hemorrhage
Condition
Stroke
Condition
Dependence
Intervention (Drug)
Colchicine 0.5 MG
Intervention (Drug)
Placebo
Lead sponsor
Population Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct06587737
Content hash
e8910b610e2badee21555fbda15a400e92ee12b6515e051598d636b4445122b6